T

TCR2 Therapeutics Inc
F:2K7

Watchlist Manager
TCR2 Therapeutics Inc
F:2K7
Watchlist
Price: 1.442 EUR 3.07%
Market Cap: 56.6m EUR

Operating Margin
TCR2 Therapeutics Inc

0%
Current
0%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-131.4m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

TCR2 Therapeutics Inc
Glance View

Market Cap
56.6m EUR
Industry
Biotechnology

TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. The company is headquartered in Cambridge, Massachusetts and currently employs 137 full-time employees. The company went IPO on 2019-02-14. The firm's T cell receptor (TCR) Fusion Construct T cells (TRuC-T cells) specifically recognize and kill cancer cells by harnessing the entire T cell receptor (TCR) signaling complex. Its lead TRuC-T cell, which targets solid tumors is gavocabtagene autoleucel (gavo-cel). The firm is conducting Phase I/II clinical trial for gavo-cel to treat patients with non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma and cholangiocarcinoma. Its other product candidates include TC-510, GPC3 and IL-15, which focuses on solid tumors, and CD70, which focuses on renal cell carcinoma. Its TC-510 is a TRuC-T cell targeting mesothelin-expressing solid tumors which incorporates a PD-1:CD28 chimeric switch receptor.

2K7 Intrinsic Value
Not Available
T
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-131.4m
/
Revenue
0
What is the Operating Margin of TCR2 Therapeutics Inc?

Based on TCR2 Therapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top